logo
AAT Bioquest

Butyrylcholinesterase Inhibitors (IC50, Ki)

Structure
Compound Name
Standard Type
Standard Values (in nM)
TacrineIC5036.0 [1]
TacrineKi7.0 [1], 8.7 [2], 8.72 [3]
DonepezilIC505580.0 [1]
DonepezilKi12540.0 [1]
GalantamineIC5010000.0 [1]
GalantamineKi192.47 [1], 192.5 [2], 28290.0 [3]
PhysostigmineIC5073.0 [1]
PhysostigmineKi5000.0 [1]
RivastigmineIC50260.0 [1]
(1S,9R,13E)-1-Amino-13-ethylidene-11-methyl-6-azatricyclo[7.3.1.02,7]trideca-2(7),3,10-trien-5-oneIC5010000.0 [1]
(1S,9R,13E)-1-Amino-13-ethylidene-11-methyl-6-azatricyclo[7.3.1.02,7]trideca-2(7),3,10-trien-5-oneKi1000.0 [1]
4,4'-(3-Oxo-1,5-pentanediyl)bis(N,N-dimethyl-N-2-propenylbenzenaminium) dibromideIC50255000.0 [1], 354000.0 [2]
4,4'-(3-Oxo-1,5-pentanediyl)bis(N,N-dimethyl-N-2-propenylbenzenaminium) dibromideKi50.0 [1]
7-Methoxy-1,2,3,4-tetrahydroacridin-9-amineIC5021000.0 [1]
Propidium iodideIC5013200.0 [1]
Bis(7)-TacrineIC505.66 [1], 9.03 [2], 38.3 [3], 54.0 [4]
Bis(7)-TacrineKi0.16 [1]
MemoquinIC501440.0 [1]
Tacrine hydrochlorideIC5023.0 [1], 40.0 [2], 43.9 [3], 44.0 [4]
BenzilIC50100000.0 [1]
BenzilKi100000.0 [1]
CaproctamineIC5011600.0 [1], 11748.98 [2], 85113800000000.0 [3]
[(8Bs)-3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl] N-phenylcarbamateIC501300.0 [1], 1560.0 [2]
Pyridostigmine bromideIC50900.0 [1], 1000.0 [2], 16000000.0 [3]
PhenserineIC501300.0 [1], 1560.0 [2], 2500.0 [3]
EptastigmineIC500.69 [1], 5.0 [2]
Ethopropazine hydrochlorideIC501600.0 [1]
Ethopropazine hydrochlorideKi12100000.0 [1]
9-Amino-6-chloro-1,2,3,4-tetrahydro-acridineIC50114.0 [1], 846.9 [2], 1730.0 [3], 1780.0 [4]
2H-1-Benzopyran-2-one, 6,7-dimethoxy-3-(4-((methyl(phenylmethyl)amino)methyl)phenyl)-IC5048900.0 [1]
7-Chloro-15-methyl-10-azatetracyclo[11.3.1.02,11.04,9]heptadeca-2,4(9),5,7,10,14-hexaen-3-amine;hydrochlorideIC50175.0 [1], 181.0 [2], 236.0 [3]
N-[8-(1,2,3,4-Tetrahydroacridin-9-ylthio)octyl]-1,2,3,4-tetrahydroacridin-9-amineIC500.77 [1]
N-[8-(1,2,3,4-Tetrahydroacridin-9-ylthio)octyl]-1,2,3,4-tetrahydroacridin-9-amineKi1.65 [1]
N-[[1-(2,3-Dihydro-1H-inden-2-yl)piperidin-3-yl]methyl]-N-(2-methoxyethyl)naphthalene-2-carboxamideIC5021.0 [1], 21.3 [2]
NeostigmineIC5016300.0 [1], 26100.0 [2], 49100.0 [3]
Edrophonium chlorideIC501370000.0 [1]
BambuterolIC503.0 [1], 4.29 [2]
Huprine YIC50153.0 [1], 175.0 [2], 181.0 [3]
(1R)-7-Chloro-15-ethyl-10-azatetracyclo[11.3.1.02,11.04,9]heptadeca-2,4(9),5,7,10,14-hexaen-3-amineIC50159.0 [1]
(1R)-7-Chloro-15-ethyl-10-azatetracyclo[11.3.1.02,11.04,9]heptadeca-2,4(9),5,7,10,14-hexaen-3-amineKi120.0 [1]
LipocrineIC5010.8 [1], 11.0 [2]
4-IsopropylphenserineIC5050.0 [1]
CymserineIC5050.0 [1], 51.0 [2]
[(8Bs)-3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl] N-(2-methylphenyl)carbamateIC501950.0 [1]
Ethyl 5-amino-4-(4-methoxyphenyl)-2-methyl-1,4,6,7,8,9-hexahydrobenzo[b][1,8]naphthyridine-3-carboxylateIC50100000.0 [1]
3-(2-Thiophen-2-yl-2,3-dihydro-1,5-benzothiazepin-4-yl)phenolIC503970.0 [1]
Ethyl 5-amino-2-methyl-4-phenyl-1,4,6,7,8,9-hexahydrobenzo[b][1,8]naphthyridine-3-carboxylateIC50100000.0 [1]
Ethyl 5-amino-4-(4-fluorophenyl)-2-methyl-1,4,6,7,8,9-hexahydrobenzo[b][1,8]naphthyridine-3-carboxylateIC50100000.0 [1]
Ethyl 5-amino-2-methyl-4-(4-methylphenyl)-1,4,6,7,8,9-hexahydrobenzo[b][1,8]naphthyridine-3-carboxylateIC50100000.0 [1]
(E)-N-[2-(1-Benzylpiperidin-4-yl)ethyl]-3-(4-hydroxyphenyl)prop-2-enamideIC50784.0 [1], 930.0 [2], 1220.0 [3]
DimethylphysostigmineIC50420.0 [1], 3000.0 [2]
3-[2-(2-Methoxyphenyl)-2,3-dihydro-1,5-benzothiazepin-4-yl]phenolIC504650.0 [1]
3-[2-(3-Chlorophenyl)-2,3-dihydro-1,5-benzothiazepin-4-yl]phenolIC5029400.0 [1]
3-[2-(4-Chlorophenyl)-2,3-dihydro-1,5-benzothiazepin-4-yl]phenolIC5076600.0 [1], 76900.0 [2], 79600.0 [3]
3-[2-(4-Methylphenyl)-2,3-dihydro-1,5-benzothiazepin-4-yl]phenolIC5075200.0 [1]
3-[2-[4-(Dimethylamino)phenyl]-2,3-dihydro-1,5-benzothiazepin-4-yl]phenolIC5034400.0 [1]
3-(2-Phenyl-2,3-dihydro-1,5-benzothiazepin-4-yl)phenolIC50142100.0 [1], 1421000.0 [2]
(2-Chlorophenyl)methyl-[2-[[2-[2-[(2-chlorophenyl)methyl-dimethylazaniumyl]ethylamino]-2-oxoacetyl]amino]ethyl]-dimethylazaniumIC506800.0 [1], 6820.0 [2], 7000.0 [3]
QuercetinIC50420760.0 [1]
QuercetinKi68000.0 [1]
Lipoic acidIC501000000.0 [1]
2,3-ButanedioneKi100000.0 [1]
RheinIC5017000.0 [1]
BenzoinKi100000.0 [1]
MethoctramineIC50977.24 [1], 1023290000000000.0 [2]
Diphosphoramide, N,N',N'',N'''-tetrakis(1-methylethyl)-IC50733.0 [1], 980.0 [2]
BenextramineIC506165.95 [1], 162181000000000.0 [2]
ProfenamineIC50300.0 [1]
ProfenamineKi20.0 [1]
1-Phenyl-1,2-propanedioneKi100000.0 [1]
CycloSal-d4TMPIC50770.0 [1]
DeoxyvasicinoneIC5025100.0 [1], 45100.0 [2]
CID 53378764IC501700.0 [1], 3300.0 [2]
(1S,13S)-7-Chloro-15-methyl-10-azatetracyclo[11.3.1.02,11.04,9]heptadeca-2,4(9),5,7,10,14-hexaen-3-amineIC50222.0 [1]
XanthostigmineIC5048.0 [1], 48000.0 [2]
5-Methyl-cyclosal-d4TMPIC504600.0 [1]
TolserineIC501950.0 [1]
(13S)-7-Fluoro-15-methyl-10-azatetracyclo[11.3.1.02,11.04,9]heptadeca-2,4(9),5,7,10,14-hexaen-3-amineIC50197.0 [1]
3-Methyl-2-(4-methylpiperazin-1-yl)-N-[7-(1,2,3,4-tetrahydroacridin-9-ylamino)heptyl]quinoline-4-carboxamideIC5040.0 [1]
(+)-PhenserineIC5023490.0 [1], 23500.0 [2]
3-[7-[N-Methyl-3-(methylcarbamoyloxy)benzylamino]heptyloxy]-9H-xanthene-9-oneIC5016.5 [1], 16500.0 [2]
1,2-Bis(3,5-difluorophenyl)ethane-1,2-dioneKi100000.0 [1]
4,4'-DifluorobenzilKi100000.0 [1]
Rac-huprine H4IC5079.3 [1]
Rac-huprine H1IC50126.0 [1], 316.0 [2]
Rac-huprine H5IC50208.0 [1], 347.0 [2]
[(8Bs)-3,8b-dimethyl-1,2,3a,4-tetrahydropyrrolo[2,3-b]indol-7-yl] N-phenylcarbamateIC50516.0 [1], 516.3 [2]
SaligcinnamideIC504840.0 [1]
SaligcinnamideKi6600.0 [1]
6-[Ethyl-[(2-methoxyphenyl)methyl]amino]-N-[8-[6-[ethyl-[(2-methoxyphenyl)methyl]amino]hexanoyl-methylamino]octyl]-N-methylhexanamideIC502238.72 [1], 2250.0 [2]
Methylbis[3-(1,2,3,4-tetrahydroacridin-9-ylamino)propyl]amineIC5010.4 [1]
Methylbis[3-(1,2,3,4-tetrahydroacridin-9-ylamino)propyl]amineKi12.13 [1]
[(8Bs)-4-benzyl-3,8b-dimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl] N-methylcarbamateIC5021.8 [1]
1,2-Bis(3,4,5-trifluorophenyl)ethane-1,2-dioneKi100000.0 [1]
1,4-Bis(phenylglyoxaloyl)benzeneKi100000.0 [1]
N'-Methyl-N-(1,2,3,4-tetrahydroacridin-9-yl)-N'-[3-(1,2,3,4-tetrahydroacridin-9-ylamino)propyl]butane-1,4-diamineKi0.82 [1]
Axillaridine AIC502490.0 [1]
Axillaridine AKi2150.0 [1]
{4-[(Benzylmethylamino)methyl]phenyl}-(4-methoxyphenyl)methanoneIC5010000.0 [1], 100000.0 [2]
BisnorcymserineIC501.0 [1]



References

This online tool may be cited as follows

MLA

"Quest Database™ Butyrylcholinesterase Inhibitors (IC50, Ki)." AAT Bioquest, Inc.21 Nov2024https://www.aatbio.com/data-sets/butyrylcholinesterase-inhibitors-ic50-ki.

APA

AAT Bioquest, Inc. (2024November 21). Quest Database™ Butyrylcholinesterase Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/butyrylcholinesterase-inhibitors-ic50-ki.
BibTeXEndNoteRefMan